Stock listing

NASDAQ:AVXS AveXis Inc Stock

Follow AveXis Inc into a list and get an email when it puts out news.

Last close · NASDAQ:AVXS

$217.83 USD

Close on May 15, 2018 · No longer trades

Feb 11, 2016 to last close +1,107% · weekly closes, Feb 11, 2016 – May 15, 2018
Lowest – highest close
$17.80 – $217.83 USDSince Feb 11, 2016 · lowest Feb 12, 2016 · highest May 14, 2018

Delisted NASDAQ:AVXS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:AVXS
Asset type
Stock
Exchange
NASDAQ
Currency
USD

AveXis Inc on 6ix

Decks
7 decks · latest Feb 27, 2018

Decks

DeckKindSlidesDate
Investor Presentation (February 2018)Investor deck15 slidesFeb 27, 2018
Corporate Update (April 2017)Corporate update23 slidesApr 25, 2017
FY2016 Earnings PresentationEarnings18 slidesMar 16, 2017
Investor Presentation (January 2017)Investor deck21 slidesJan 9, 2017
Corporate Update (October 2016)Corporate update21 slidesOct 11, 2016
Q2 2016 Earnings PresentationEarnings16 slidesAug 11, 2016
Technical Presentation (May 2016)Technical21 slidesMay 6, 2016

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
James Flynn
Other companies: Lite Strategy, Inc. (Director · Since at least Oct 31, 2023); Nuvalent, Inc. (Director · Since at least Jul 28, 2021); Larimar Therapeutics, Inc. (Director · Since at least May 28, 2020); Synlogic Inc (Director · Mar 19, 2024 – Apr 26, 2025 · Past); BiomX Inc. (Director · Mar 15, 2024 – Apr 21, 2025 · Past); Oruka Therapeutics, Inc. (Director · Jan 30, 2024 – Jan 30, 2024 · Past); RiceBran Technologies (Director · Jan 3, 2024 – Jan 3, 2024 · Past); CareMax Inc (Director · Nov 17, 2022 – Nov 17, 2023 · Past); ARS Pharmaceuticals, Inc. (Director · Nov 8, 2022 – Nov 8, 2022 · Past); Da32 Life Science Tech Acquisition Corp (Director · Jul 27, 2021 – Jul 28, 2023 · Past); Oncorus Inc (Director · Oct 1, 2020 – Feb 17, 2021 · Past); Acutus Medical Inc. (Director · Aug 5, 2020 – Jan 27, 2025 · Past); Deerfield Healthcare Technology Acquisitions Corp (Director · Jul 16, 2020 – Jul 21, 2020 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 6, 2019 · Past); AdaptHealth Corp. (Director · Feb 15, 2018 – Nov 8, 2019 · Past); Alpine Immune Sciences Inc (Director · Sep 12, 2016 – Sep 12, 2016 · Past)
Director · Sep 3, 2015 – Feb 10, 2016 · Past
Daniel G. Welch
Other companies: Prothena Corporation plc (Chair of the Board · Since at least Feb 21, 2024); Structure Therapeutics, Inc. (Director · Since at least Feb 2, 2023); Ultragenyx Pharmaceutical Inc. (Director · Since at least Apr 8, 2015); Nuvation Bio Inc. (Director · Feb 10, 2021 – May 24, 2024 · Past); Intercept Pharmaceuticals Inc (Director · Nov 24, 2015 – May 28, 2020 · Past); Corium International Inc (Director · Apr 2, 2014 – Apr 2, 2014 · Past); Hyperion Therapeutics Inc (Director · Aug 23, 2012 – May 7, 2015 · Past); Seagen Inc (Director · Jun 13, 2007 – Dec 14, 2023 · Past); InterMune Inc (Chairman, CEO and President, Director · Mar 15, 2006 – Sep 29, 2014 · Past)
Director · Feb 10, 2016 – May 15, 2018 · Past
Jonathan Leff
Other companies: Larimar Therapeutics, Inc. (Director · Since at least May 28, 2020); BiomX Inc. (Director · Mar 15, 2024 – Apr 14, 2025 · Past); ARS Pharmaceuticals, Inc. (Director · Nov 8, 2022 – Nov 8, 2022 · Past); Protara Therapeutics, Inc. (Director · Aug 2, 2017 – Jun 8, 2018 · Past); Alpine Immune Sciences Inc (Director · Jun 16, 2015 – Sep 11, 2015 · Past); InterMune Inc (EVP, Research & Development · Feb 27, 2012 – Sep 29, 2014 · Past)
Director · Feb 10, 2016 – Feb 10, 2016 · Past
Paul B. Manning
Other companies: Candel Therapeutics, Inc. (Chair of the Board · Since at least Jul 26, 2021); Liquidia Corporation (Board Member · Since at least Nov 18, 2020); Verrica Pharmaceuticals Inc. (Chairman · Since at least Jun 14, 2018); Taysha Gene Therapies, Inc. (Director · Sep 23, 2020 – Oct 31, 2022 · Past); Dova Pharmaceuticals Inc (Director · Jun 28, 2017 – Nov 12, 2019 · Past); Perrigo Company plc (EVP & General Manager, PBM · Jun 9, 2010 – Jun 9, 2010 · Past)
Director · Feb 10, 2016 – Feb 10, 2016 · Past
Phillip Donenberg
Other companies: Sensei Biotherapeutics, Inc. (Chair of the Audit Committee · Since at least Feb 13, 2026); Taysha Gene Therapies, Inc. (Director · Since at least Sep 23, 2020); Tectonic Therapeutic, Inc. (Director · Since at least Jun 20, 2018); Depomed Inc (SVP and CFO · Jul 16, 2018 – Jul 16, 2018 · Past); CervoMed Inc. (Director · May 27, 2014 – Jul 24, 2014 · Past); ANI Pharmaceuticals, Inc. (Sr VP of Finance, CFO, Secy · Mar 16, 2006 – Jan 25, 2012 · Past)
Chief Financial Officer · Oct 19, 2017 – May 15, 2018 · Past
Sean P. Nolan
Other companies: Taysha Gene Therapies, Inc. (Chief Executive Officer and Board Chairman · Since at least Sep 23, 2020); Ventas, Inc. (Director · Since at least Jul 26, 2019); Social Capital Suvretta Holdings Corp II (Director · Sep 24, 2021 – Sep 24, 2021 · Past); Neurogene Inc. (Director · Feb 16, 2015 – May 5, 2020 · Past); InterMune Inc (EVP & CBO · Feb 11, 2013 – Sep 29, 2014 · Past)
President & CEO, Director · Feb 10, 2016 – May 15, 2018 · Past
Sukumar Nagendran
Other companies: Taysha Gene Therapies, Inc. (Director · Since at least Sep 23, 2020); Solid Biosciences Inc. (President, Head of Research & Development, Taysha Gene Therapies · Since at least Sep 12, 2018); Immunovant, Inc. (Director · May 9, 2019 – May 9, 2019 · Past)
Sr. VP & Chief Medical Officer · Feb 10, 2016 – May 15, 2018 · Past
Rick Modi
Other companies: Astria Therapeutics Inc (Chief Business Officer · Jun 24, 2015 – Sep 8, 2016 · Past)
Chief Business Officer · Feb 13, 2017 – May 15, 2018 · Past
Bong Y KohDirector · Feb 10, 2016 – May 15, 2018 · Past
James J LitalienSrVP/Chief Reg&Quality Officer · Feb 10, 2016 – May 15, 2018 · Past
All 11 people
PersonSeat
Lori J SmithSVP-Chief Human Resource Off. · Mar 13, 2018 – May 15, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about AveXis Inc.